Sophie Maiocchi

Dr Maiocchi joined the CCNTP as an Associated Fellow in 2022. She studies the vascular delivery of redox interventions and biologic therapies, such as proteins and mRNA, using polymeric nanoparticles coupled with cell-mediated delivery. Dr Maiocchi received her B.Sc.(Hons) in Nanotechnology and Ph.D in Pathology at the University of New South Wales, finishing in 2016. She trained for 2 years in the Thrombosis Group at the University of Sydney, after which she joined the Center for Nanotechnology in Drug Delivery at UNC in 2019, in the lab of Dr Edward Bahnson. Notable achievements include an NHLBI K99/R00 Career Development Award in 2022, entitled “Targeted drug delivery for the treatment of cardiovascular disease and its clinical complications”. In her time at UNC, she has received the Leon and Bertha Golberg Fellowship from the Curriculum in Toxicology and Environmental Medicine (2020), an NC TraCS 2K Pilot Award (2020) and the Burroughs Wellcome Fund Collaborative Travel Grant (2020), as well as two Young Investigator Awards at the 2020 and 2021 Annual Meetings of the Society for Redox Biology and Medicine. Her full bibliography can be found at: https://www.ncbi.nlm.nih.gov/myncbi/10InkyudBVOEqm/bibliography/public/.